Becton Dickinson and Co (BDX)
12 Mar 2014
|Market Cap (Mil.):||$22,288.15|
|Shares Outstanding (Mil.):||193.02|
NEW YORK, Dec 17 - Biodel Inc : * Up 10.5 percent premarket after supply agreement with Becton Dickinson for liquid glucagon rescue device
- Medical technology company Becton Dickinson & Co said on Tuesday that quarterly net income fell as costs rose sharply, but after excluding litigation charges and pension settlements, the results were higher than analysts had expected.
Nov 5 - Medical technology company Becton Dickinson & Co said on Tuesday that quarterly net income fell as costs rose sharply, but after excluding litigation charges and pension settlements, the results were higher than analysts had expected.
Sept 20 - Becton Dickinson and Co said it may have to pay up to $340 million after a federal jury found the medical device maker guilty of attempting to monopolize the safety syringe market through deceptive practices.
|Baxter International Inc. (BAX.N)||$67.62||-0.13|
|Covidien plc (COV.N)||$71.14||+0.07|
|Stryker Corporation (SYK.N)||$81.63||0.00|
|Boston Scientific Corporation (BSX.N)||$12.88||-0.30|
|C.R. Bard, Inc. (BCR.N)||$146.43||+0.65|
|Hologic, Inc. (HOLX.OQ)||$22.11||-0.10|
|Quidel Corporation (QDEL.OQ)||$28.44||-0.59|
Earnings vs. Estimates
Analyst Research Reports
Provider: Pechala's Reports
Trading Report for (BDX). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Provider: Thomson Reuters Stock Report
Provider: Wright Reports
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.